StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Stronger Oncor earnings, record capex and anticipated rate-base growth bolster SRE's consolidated earnings power and long-term value; regulatory progress supports visibility on future returns.
What happened, with direct paths to the underlying reporting
Oncor reported Q3 2026 net income of $572 million, up from $380 million a year earlier, led by higher regulated revenues from new base rates, UTM and SRP. The company plans about $9 billion of capex in 2026 and a 2027–2031 plan that’s up roughly 20%. As Sempra owns Oncor, rising Texas capex and rate-base growth support SRE's earnings trajectory.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.